SCHEMBL21752970

SCHEMBL21752970

CN(O)C(c1ccc(Oc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)cc1)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP2 P42575 2/20 0.40
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 4/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 2/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
ESR1 P03372 1/20 0.37
HTT P42858 2/20 0.37
RAD52 P43351 2/20 0.37
NPC1 O15118 1/20 0.36
EPHX2 P34913 2/20 0.35
MAPT P10636 1/20 0.35
POLB P06746 1/20 0.35
GFER P55789 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
MDH1 P40925 1/20 0.34
MDH2 P40926 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21769975 0.94 CASP2 (0.36) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL21752971 0.90 MEN1 (0.40) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL21769895 0.84 LMNA (0.35) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL21753070 0.82 LMNA (0.34) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL21752924 0.81 MEN1 (0.44) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL21769893 0.78 LMNA (0.33) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL21752969 0.78 MEN1 (0.40) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL27845478 0.75 LMNA (0.61) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL21769896 0.72 MEN1 (0.35) CASP2MEN1KMT2ARAB9ALMNA
SCHEMBL16216731 0.71 LMNA (0.52) CASP2MEN1KMT2ARAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3840834-A2 AROMATIC MOLECULES FOR USE IN THE TREATMENT OF PATHOLOGICAL CONDITIONS Xeniopro GmbH (DE) 2021-06-30 EP disclosed
WO-2020039088-A2 NOVEL COMPOUNDS Xeniopro GmbH (DE) 2020-02-27 WO disclosed